HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

dopamine quinone

product of the autoxidation of dopamine

Also Known As:

dopaminoquinone

Networked: 10 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Amines: 4871
  - Catecholamines: 15682
    - Dopamine: 23033
      - dopamine quinone: 10
  - Biogenic Amines: 992
    - Biogenic Monoamines: 29
      - Dopamine: 23033
        dopamine quinone: 10
- Hydrocarbons: 1713
  - Cyclic Hydrocarbons: 97
    - Aromatic Hydrocarbons: 291
      - Benzene Derivatives: 17
        Phenols: 677
        Catechols: 121
        Catecholamines: 15682
        Dopamine: 23033
        dopamine quinone: 10

Experts

1.	Asanuma, Masato: 3 articles (01/2008 - 01/2003)
2.	Miyazaki, Ikuko: 3 articles (01/2008 - 01/2003)
3.	Cavalieri, Ercole L: 2 articles (12/2011 - 08/2011)
4.	Zahid, Muhammad: 2 articles (12/2011 - 08/2011)
5.	Ogawa, Norio: 2 articles (10/2004 - 01/2003)
6.	Beseler, Cheryl: 1 article (12/2011)
7.	Rogan, Eleanor: 1 article (12/2011)
8.	Saeed, Muhammad: 1 article (12/2011)
9.	Yang, Li: 1 article (12/2011)
10.	Beseler, Cheryl L: 1 article (08/2011)

Related Diseases

1.	Parkinson Disease (Parkinson's Disease) 03/01/2008 - "Proteomic analysis of rat brain mitochondria following exposure to dopamine quinone: implications for Parkinson disease." 12/01/2011 - "Formation of dopamine quinone-DNA adducts and their potential role in the etiology of Parkinson's disease." 03/12/2010 - "Oxidized metabolites of dopamine known as dopamine quinone derivatives are thought to play a pivotal role in the degeneration of nigrostriatal dopaminergic neurons in Parkinson's disease. " 12/14/2007 - "An abnormal accumulation of cytosolic dopamine resulting in reactive oxygen species and dopamine-quinone products may play an important role in the rather selective degeneration of substantia nigra pars compacta (SNc) dopaminergic neurons in Parkinson's disease. " 10/01/2005 - "In this work, we demonstrate that oxidized products of dopamine (neurotoxic dopamine quinone), a neurotransmitter involved in Parkinson's disease, promote tau polymerization. "
2.	Parkinsonian Disorders (Parkinsonism) 10/01/2004 - "Recently, the neurotoxicity of dopamine quinone formation by auto-oxidation of dopamine has been shown to cause specific cell death of dopaminergic neurons in the pathogenesis of sporadic PD and dopaminergic neurotoxin-induced parkinsonism. "

Related Drugs and Biologics

1.	Dopamine (Intropin)
2.	PPAR gamma
3.	DNA Adducts
4.	Neuroprotective Agents
5.	Neurotransmitter Agents (Neurotransmitter)
6.	Reactive Oxygen Species (Oxygen Radicals)
7.	Monophenol Monooxygenase (Tyrosinase)
8.	Quinones
9.	Nitric Oxide (Nitrogen Monoxide)
10.	Neurotoxins